Sartorius AG (XTER:SRT) Other Long-Term Liabilities : €576 Mil (As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Sartorius AG Other Long-Term Liabilities?

Sartorius AG's other long-term liabilities for the quarter that ended in Mar. 2024 was €576 Mil.

Sartorius AG's quarterly other long-term liabilities declined from Sep. 2023 (€768 Mil) to Dec. 2023 (€588 Mil) and declined from Dec. 2023 (€588 Mil) to Mar. 2024 (€576 Mil).

Sartorius AG's annual other long-term liabilities declined from Dec. 2021 (€617 Mil) to Dec. 2022 (€472 Mil) but then increased from Dec. 2022 (€472 Mil) to Dec. 2023 (€588 Mil).

Sartorius AG Other Long-Term Liabilities Historical Data

The historical data trend for Sartorius AG's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sartorius AG Other Long-Term Liabilities Chart

Sartorius AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Sartorius AG Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Sartorius AG Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Sartorius AG Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Sartorius AG's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sartorius AG (XTER:SRT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sartorius AG (XTER:SRT) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

SOAGY:USA SSSGY:USA SUVPF:USA SARTF:USA 1SRT3:Italy SRT3d:UK 0NIR:UK SRT3:Germany SRT3:Austria

Address

Otto-Brenner-Strasse 20, Gottingen, NI, DEU, 37079

Website

https://www.sartorius.com

Sartorius AG is a leading provider of bioprocessing solutions. Its Bioprocess division sells equipment and consumables for upstream and downstream manufacturing of biologic drugs, and has a focus on single-use technology, or SUT. Its Lab Products and Services division offers a wide range of products for lab use, including scales, pipettes, and filtration equipment. As of 2022, the Bioprocess and LPS divisions contributed 80% and 20% of revenue, respectively. Bioprocess is housed in its subsidiary Sartorius Stedim Biotech, of which Sartorius AG has a 74% ownership and 85% voting control. The business is geographically diverse, with revenue across Europe, the Middle East, and Africa (37% of 2022 sales), the Americas (37%), and Asia-Pacific (26%). We estimate China revenue to be around 10%.